zhejiang tianyu pharmaceutical (300702.SZ) announcement, the company's wholly-owned subsidiary zhejiang nuode pharmaceutical co., Ltd. (referred to as "nuode...
According to the Zhito Finance APP, Zhejiang Tianyu Pharmaceutical (300702.SZ) announced that its wholly-owned subsidiary Zhejiang Nuode Pharmaceutical Co., Ltd. (referred to as "Nuode Pharmaceutical") participated in the bidding for the tenth batch of national centralized procurement organized by the National Organization for Pharmaceutical Joint Procurement Office (referred to as "Joint Procurement Office") on December 12, 2024. Nuode Pharmaceutical's products, sitagliptin and metformin tablets (II) and sitagliptin phosphate tablets, are expected to be selected for this centralized procurement.